Historical record - last NADAC effective date: 5/18/2016
Product Information
ESTROGEN-METHYLTESTOS F.S. TAB is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $2.7860 per EA under NDC 53746007801. Its NADAC has been published 29 times since Aug 19, 2015.
Strength
1.25; 2.5 mg/1; mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
53746007801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/18/2016
Active Ingredients
ESTROGENS, ESTERIFIED; METHYLTESTOSTERONEApproval Type
Unapproved
On Market Since
9/22/2010
Pharmacological Classes
Price Statistics
The NADAC for ESTROGEN-METHYLTESTOS F.S. TAB has been published 29 times since Aug 19, 2015, and over the history we have for it it has risen 4.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.7860 per EA |
|---|---|
| All-time high | $2.7860 (Jun 1, 2016) |
| All-time low | $2.6604 (Aug 19, 2015) |
| Median price | $2.6604 |
| Average price | $2.6734 |
| Largest weekly change | +4.7% (May 18, 2016) |
| Weeks tracked | 29 |
| Tracking since | Aug 19, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+4.7%
Last surveyed Jun 1, 2016 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Esterified Estrogens and Methyltestosterone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Esterified Estrogens and Methyltestosterone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Androgen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ESTROGEN-METHYLTESTOS F.S. TAB?
The current National Average Drug Acquisition Cost (NADAC) for ESTROGEN-METHYLTESTOS F.S. TAB, manufactured by Amneal Pharmaceuticals of New York LLC, is $2.7860 per EA (NDC 53746007801), effective Jun 1, 2016.
How has the price of ESTROGEN-METHYLTESTOS F.S. TAB changed over time?
Over the history we have for it, the NADAC for ESTROGEN-METHYLTESTOS F.S. TAB has risen 4.7%. It has been tracked across 29 weekly CMS publications since Aug 19, 2015.
What are the highest and lowest recorded NADAC prices for ESTROGEN-METHYLTESTOS F.S. TAB?
Since Aug 19, 2015, the NADAC for ESTROGEN-METHYLTESTOS F.S. TAB has ranged from a low of $2.6604 (Aug 19, 2015) to a high of $2.7860 (Jun 1, 2016), with a median of $2.6604 per EA.
Are there cheaper alternatives to ESTROGEN-METHYLTESTOS F.S. TAB?
No other NADAC-published product currently shares the active ingredient and strength of ESTROGEN-METHYLTESTOS F.S. TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ESTROGEN-METHYLTESTOS F.S. TAB?
ESTROGEN-METHYLTESTOS F.S. TAB (NDC 53746007801) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.